No recommendations so far.What's your call on Hikal today? Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2551.00||-0.20||2939.80||1904.15||43,394.77|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Hikal is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 795.70 crore.The company has reported a standalone sales of Rs 216.42 crore and a Net Profit of Rs 10.28 crore for the quarter ended Dec 2013.
The company management includes Jai Hiremath - Chairman & Managing Director, Sameer Hiremath - Joint Managing Director, Baba Kalyani - Director, Prakash Mehta - Director, Shivkumar Kheny - Director, Kannan Unni - Director, Peter Pollak - Director, Amit Kalyani - Director, Wolfgang Welter - Director, Sugandha Hiremath - Director.
It is listed on the BSE with a BSE Code of 524735 and the NSE with an NSE Code of HIKAL.
Its Registered office is at 717/718, Maker Chambers V,,Nariman Point Mumbai,Maharashtra - 400021.
Their Registrars are Universal Capital Securities Pvt. Ltd.